Morningstar’s biotech strategist Karen Anderson and energy analyst Preston Caldwell are calling the COVID-19 market sell-off a “gross overreaction” to a…
Morningstar’s biotech strategist Karen Anderson and energy analyst Preston Caldwell are calling the COVID-19 market sell-off a “gross overreaction” to a…